Novavax reported 2.01 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Adma Biologics 12.28 2.74 Jun/2026
AstraZeneca 24.63 0.71 Sep/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
MannKind 201.15 102.55 Mar/2026
Merck 34.36 2.11 Sep/2026
Moderna 27.22 14.51 Jun/2023
Novartis 21.54 0.18 Sep/2026
Novavax 2.01 1.07 Dec/2025
Pfizer 15.2 3.72 Sep/2026
Sanofi 22.34 3.38 Sep/2026
Sarepta Therapeutics 32.09 22.66 Sep/2026
TG Therapeutics 75.56 55.92 Sep/2026